PTCT

PTC Therapeutics, Inc.

Investor Moves

Name	Value	Action	Change	Price	Last Price
Steven CohenPoint72 $-85.7M ExitQ1 2026 $86M $70.81 $78.52
Ken GriffinCitadel Advisors $28M413.5k shares TrimQ1 2026 $61M $70.81 $78.52
Paul Tudor Jones IITudor Investment $3M42.2k shares AddQ1 2026 $2M $70.81 $78.52
Ray DalioBridgewater Associates $-1.2M ExitQ1 2026 $1M $70.81 $78.52
Jim SimonsRenaissance Technologies $36M533.3k shares TrimQ1 2026 $10M $70.81 $78.52
Chuck RoyceRoyce & Associates $6M92.8k shares AddQ1 2026 $187k $70.81 $78.52

Insider Trades

Name	Value	Action	Price	Last Price
Boulding Mark ElliottEXEC. VP AND CLO $170k2.4k shares SellMay 15, 2026 $72.08 $78.52
Boulding Mark ElliottEXEC. VP AND CLO $33k456 shares SellMay 15, 2026 $72.67 $78.52
Klein Matthew B.Director, Officer: CHIEF EXECUTIVE OFFICER $528k7.2k shares SellMay 14, 2026 $73.08 $78.52
Klein Matthew B.Director, Officer: CHIEF EXECUTIVE OFFICER $186k2.6k shares SellMay 14, 2026 $72.46 $78.52
Klein Matthew B.Director, Officer: CHIEF EXECUTIVE OFFICER $153k2.1k shares SellMay 14, 2026 $73.08 $78.52
Klein Matthew B.Director, Officer: CHIEF EXECUTIVE OFFICER $50k679 shares SellMay 14, 2026 $73.06 $78.52

About PTC Therapeutics, Inc.

PTC Therapeutics, Inc. is listed in the TradingNote stock universe. Smart money activity will appear here when matching public disclosures are available.

Market Data

Open: $79.58
High: $80.00
Low: $78.10
Volume: 2.4M
Avg Volume: 1.4M
52W High: $87.50
52W Low: $43.18

Valuation

Market Cap: $6.6B
Enterprise Value: $6.1B
Dividend Yield: 0.00%

Financials

Free Cash Flow: $702.3M
Revenue: $1.7B
Net Income: $682.6M
Cash: $984.6M
Debt: $492.3M